Blood-Based Test Can Predict Risk of Developing Symptoms of Alzheimer’s Up to a Decade Early
Key Takeaways A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged around the extent to which such tests can accurately predict whether a cognitively healthy individual will go on to develop cognitive impairment—a key symptom of Alzheimer’s disease. A new, international study involving researchers across three